ClinicalTrials.gg
Not yet recruitingNCT07948057Updated Nov 19, 2026

Validation of Buccolingual Ridge Width Measurements on CBCT Using Direct Intraoperative Measurements

An observational study in Dental Implant and Alveolar Ridge Assessment, sponsored by Tanta University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Tanta University · Observational

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to validate the accuracy of cone beam computed tomography (CBCT) in assessing buccolingual ridge width at posterior mandibular implant sites by comparing CBCT-derived measurements with standardized direct intraoperative caliper measurements obtained at the planned implant position.

Read the detailed description

The alveolar ridge is a dynamic anatomical structure that undergoes continuous remodeling throughout life in response to functional and biological changes. Following tooth extraction, progressive dimensional alterations occur in the alveolar bone, resulting in reduction of ridge height and width. Several studies have demonstrated that post-extraction bone resorption predominantly affecting the buccolingual dimension, leading to changes in ridge morphology and contour(1, 2). These dimensional changes may complicate accurate radiographic and clinical assessment of the residual alveolar ridge(3).

The success of implant therapy is influenced by several endogenous and exogenous factors. Endogenous factors include the quality and quantity of the supporting alveolar bone, whereas exogenous factors include implant length, diameter, design, and surgical technique. Bone quality varies considerably among different regions of jaws. In general, the mandible demonstrates denser cortical bone than the maxilla, while posterior regions of both jaws tend to exhibit reduced cortical thickness and increased trabecular porosity(4). Therefore, accurate assessment of alveolar bone dimensions is considered a fundamental prerequisite for proper implant planning and successful treatment outcomes(5).

The posterior mandibular region exhibits considerable anatomical variability in alveolar ridge morphology and cortical bone configuration. Buccolingual ridge width in this region may be influenced by residual ridge resorption, cortical plate thickness, and individual anatomical characteristics. In addition, the lingual aspect of the posterior mandible may present anatomical concavities that increase the complexity of ridge assessment and necessitate accurate evaluation of bone dimensions prior to the surgical procedures(6).

Accurate evaluation of buccolingual ridge dimensions is essential for reliable assessment of alveolar bone morphology. Inaccurate estimation of ridge width may result in discrepancies between radiographic findings and actual bone dimensions. Therefore, precise and reproducible measurement methods are required to ensure reliable assessment of alveolar ridge width, particularly in posterior mandibular regions where anatomical variations including lingual concavities and undercut are frequently encountered(5).

Conventional two-dimensional radiographic techniques, including panoramic and periapical radiography, have been widely used for assessment of alveolar bone. However, these imaging modalities have several limitations related to magnification, distortion, superimposition, and inability to evaluate the buccolingual dimension of the alveolar ridge. Such limitations may reduce the accuracy of linear measurements and compromise reliable assessment of bone morphology in posterior mandibular regions(7).

The inherent limitations of conventional two-dimensional imaging techniques have increased the demand for volumetric imaging modalities capable of providing accurate three-dimensional visualization of alveolar bone morphology. Three-dimensional imaging modality eliminates the superimposition and geometric distortion commonly associated with conventional radiography and enables precise multiplanar reconstruction of osseous structures in the axial, coronal, and sagittal planes(8).This capability enables more accurate assessment of the buccolingual dimension of the alveolar ridge and improves radiographic evaluation of anatomical structures in posterior mandibular regions. Consequently, volumetric imaging modalities have become increasingly important for accurate evaluation of alveolar bone dimensions and morphology(9).

Cone-beam computed tomography (CBCT) has become widely utilized in dentomaxillofacial imaging because of its ability to provide high-resolution three-dimensional images with relatively low radiation exposure compared with conventional computed tomography. CBCT enables accurate linear measurements of alveolar bone dimensions and facilitates detailed evaluation of anatomical structures relevant to implant site assessment and surgical planning(9).

Although CBCT has demonstrated high accuracy in assessment of alveolar bone dimensions, validation of CBCT-derived measurements under clinical conditions remains essential. Minor discrepancies between radiographic measurements and actual bone dimensions may still occur due to factors related to image acquisition, voxel size, observer variability, and image interpretation(10). Therefore, direct intraoperative measurements continue to be considered an important reference standard for evaluation of the accuracy and reproducibility of CBCT linear measurements(11).

Direct intraoperative measurements provide accurate assessment of alveolar bone dimensions and are considered the reference standard for validating radiographic measurements in clinical studies. The variations in measurement techniques, anatomical reference points, and imaging protocols may influence the reported accuracy of CBCT measurements. Consequently, further validation studies remain necessary to assess the reliability of CBCT measurements in anatomically variable posterior mandibular regions(12).

Although previous validation studies have reported favorable agreement between CBCT-derived measurements and direct intraoperative measurements in posterior mandibular implant sites, these studies have not employed standardized localization devices to ensure identical measurement points between the radiographic and surgical phases(12, 13). The absence of a standardized point localization method may introduce positional variability in reported measurements, potentially affecting the reliability of comparison outcomes(13). Ridge mapping by CBCT needs to be compared to what would seem to be the most accurate measurement, which is direct caliper measurement following surgical exposure of the bone(11, 14). Therefore, a validated measurement protocol incorporating a standardized stent-based localization device is required to ensure reproducible and accurate comparison between CBCT-derived and intraoperative ridge width measurements.

To the best of our knowledge, there are insufficient clinical studies that have compared CBCT-derived buccolingual ridge width measurements with direct intraoperative caliper measurements obtained at standardized levels corresponding to planned implant positions in posterior mandibular sites. Therefore, the aim of the present study is to validate the accuracy and reliability of buccolingual ridge width measurements obtained from cone-beam computed tomography (CBCT) by comparing them with direct intraoperative caliper measurements in posterior mandibular implant sites using a standardized stent-based localization protocol.

The null hypothesis of the present study is that there will be no statistically significant difference between buccolingual ridge width measurements obtained from CBCT and those obtained through direct intraoperative measurements at posterior mandibular implant sites.

02

Conditions studied

  • Dental Implant
  • Alveolar Ridge Assessment
03

In context

Lead sponsor

Tanta University is the lead sponsor of 1,015 studies on the registry; 321 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults aged 18 years or older who are scheduled for single-tooth dental implant placement in the posterior mandible at a previously extracted mandibular first or second molar site. Participants must have sufficient post-extraction healing, identifiable buccolingual ridge morphology, and adequate residual alveolar bone dimensions for implant placement. Patients must be in good general health, have a stable periodontal condition without active inflammation, and meet all inclusion criteria while excluding those with conditions or factors that may interfere with implant surgery or bone healing.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Site in Patients aged 18 years or above.
  2. Patients indicated for posterior mandibular implant placement at the site of a previously extracted mandibular first or second molar.
  3. Sufficient post-extraction healing time with preservation of identifiable buccolingual ridge morphology including lingual ridge contour.
  4. Adequate residual alveolar bone dimensions to permit implant placement.
  5. Patients in good general health with no systemic conditions for implant surgery.
  6. Patients with stable periodontal condition and no signs of active inflammation.

Exclusion criteria

Exclusion Criteria:

  1. History of or head and neck radiation therapy.
  2. Uncontrolled systemic diseases for surgical procedures.
  3. Active periodontal infection or acute inflammation at the planned implant site.
  4. History of periodontal or bone augmentation surgery at the planned site.
  5. Parafunctional occlusal habits including bruxism or clenching.
  6. Pregnant or lactating females.
  7. Patients with smoking habits that may affect bone healing.
  8. Insufficient residual alveolar bone dimensions precluding implant placement without augmentation procedures.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • ProcedureCBCT imaging and standardized intraoperative ridge-width measurement

    Participants will undergo clinically indicated CBCT imaging before implant placement using a customized vacuum-formed thermoplastic stent with gutta-percha radiopaque markers. Buccolingual alveolar ridge width will be measured on CBCT cross-sectional images at the marker level by two independent examiners. During implant surgery, before implant placement, direct buccolingual ridge width will be measured with a caliper through the corresponding stent holes. The dental implant will then be placed according to the standard clinical protocol.

06

What researchers measure

Primary outcomes

  1. Difference between CBCT-derived and direct intraoperative buccolingual ridge width

    Mean difference, absolute difference, and agreement between buccolingual alveolar ridge width measured on CBCT cross-sectional images and direct intraoperative caliper measurements at the standardized stent-based planned implant position. Measurements will be recorded in millimeters (mm).

    Time frame: At the time of implant placement surgery (before implant placement

Secondary outcomes

  1. Interobserver and intraobserver reliability of CBCT buccolingual ridge-width measurements

    reproducibility of CBCT-derived buccolingual alveolar ridge-width measurements, assessed as intraobserver and interobserver agreement between repeated measurements by two independent calibrated examiners. Measurements will be recorded in millimeters (mm)."

    Time frame: At CBCT image analysis, before implant placement surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 19, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Nov 30, 2027
CompletionEst.
Dec 30, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948057
Lead sponsor
Tanta University
Responsible party
Nayra Mohammed Ahmed Zaki (Doctor, Tanta University) — Principal investigator
First posted
Nov 19, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Nov 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Nayra Mohammed zaki, master degree=
Contact
PG_198213@dent.tanta.edu.eg
+201205233092
Dr. Malak Youssef Mohammed, professor
principal investigator · Faculty of Dentistry, Tanta University, Egypt

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion